Pancreatic Cancer Research

ResearcherThe University of OsakaActive in the last 2 years

Daiki Marukawa

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 8 November 2026

Matched on OpenAlex author ID A5040658407. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2023: 1 paper · 2024: 1 paper

Papers 2

  1. Clinical impact of high-quality testing for peritoneal lavage cytology in pancreatic cancer. Co-author DOI 10.1038/s41598-024-60936-4↗
  2. Rubicon can predict prognosis in patients with pancreatic ductal adenocarcinoma after neoadjuvant chemoradiotherapy. Co-author DOI 10.1007/s10147-023-02306-0↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Masahiro Tanemura · 2 shared papers, 2023–2024 · strength 0.37
  2. Tadafumi Asaoka · 2 shared papers, 2023–2024 · strength 0.37
  3. Hidetoshi Eguchi · 2 shared papers, 2023–2024 · strength 0.37
  4. Daisaku Yamada · 2 shared papers, 2023–2024 · strength 0.37
  5. Manabu Mikamori · 1 shared paper, 2024 · strength 0.21
  6. Kenta Furukawa · 1 shared paper, 2024 · strength 0.21
  7. Yuichiro Doki · 1 shared paper, 2023 · strength 0.16
  8. Yoshifumi Iwagami · 1 shared paper, 2023 · strength 0.16
  9. Hirofumi Akita · 1 shared paper, 2023 · strength 0.16
  10. Yoshito Tomimaru · 1 shared paper, 2023 · strength 0.16
  11. Kunihito Gotoh · 1 shared paper, 2023 · strength 0.16
  12. Hidenori Takahashi · 1 shared paper, 2023 · strength 0.16
  13. Kazuki Sasaki · 1 shared paper, 2023 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.